Exorna Bioscience
Clinical trials sponsored by Exorna Bioscience, explained in plain language.
-
Experimental Huntington's drug shows promise in small safety study
Disease control CompletedThis early-stage study tested an experimental drug called ER2001 in 8 adults with early Huntington's disease. The main goal was to check if the drug is safe and how the body processes it. Participants received increasing doses of the drug through an IV over 6 weeks. This study is…
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated May 26, 2026 12:07 UTC
-
New Huntington's drug shows promise in small safety study
Disease control CompletedThis early study tested a new drug, ER2001, in 10 adults with early Huntington's disease. The main goal was to check if the drug is safe and how the body processes it. Researchers also looked for early signs that the drug might help control the disease.
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated May 20, 2026 11:54 UTC